DeepLife
PrivateLast Round
Series A
Dec 10, 2024
Total Funding Raised
$15.87M
Company Overview
DeepLife operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in December 2024.
DeepLife is a biotechnology company that develops an AI-powered SaaS platform using digital twins of cells to accelerate drug discovery, target identification, and cell engineering for pharmaceutical and biotech partners.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeepLife Comparables
Compare DeepLife with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cytocast | 84% | |
| Turbine | 80% | |
| VeriSIM Life | 78% |
For institutional investors. Book with your work email.
DeepLife Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 10, 2024 | ||||
| Seed | Aug 3, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DeepLife Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Turenne Groupe | Series A |
| Paris Business Angels | Seed |
| Oscar & Paul Beiersdorf Venture Capital | Series A |
| Groupe Prunay | Series A |
| YZR Capital | Series A |
| ESSEC Alumni Business Angels | Seed |
| MABA | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
Monthly visitors grew 303% MoM, reaching 1.9K.
- Nov 15, 2025
Grew 19% QoQ, from 31 to 37 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 11, 2026
DeepLife Group signs a joint research agreement with South Korean biotech company 3 billion at Bio-Europe 2026 to advance AI-driven drug discovery.
- is_developingNov 9, 2026
DeepLife Group announces a co-development collaboration with 3 billion to discover and develop small-molecule therapeutics against novel targets, focusing on genetic modifiers and combining TwinCell virtual cell technology with genomic insights and AI-driven medicinal chemistry in France and South Korea on Nov 9th '26.
- hiresSep 10, 2026
DeepLife Group appoints Jakob E. Larsen as an advisor to its Advisory Board alongside Ivan Griffin.
- hiresSep 10, 2026
DeepLife Group appoints Ivan Griffin, co-founder of BenevolentAI, as an advisor to its Advisory Board.
For institutional investors. Book with your work email.
DeepLife Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DeepLife's valuation, stock price, and market status.
Is DeepLife a public or private company?
DeepLife is a private company.
What is the current stock price of DeepLife?
DeepLife is a private company, so its shares have no public market price. Caplight tracks DeepLife's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DeepLife worth (valuation)?
Valuation information for DeepLife is not publicly available.
Can I buy DeepLife stock?
DeepLife shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DeepLife's last funding round?
DeepLife's most recent funding round was Series A on December 10, 2024.
Who are the main investors in DeepLife?
Key investors in DeepLife include YZR Capital.
Will DeepLife IPO soon?
No public IPO plans have been announced for DeepLife.
How can I track DeepLife secondary market activity?
Caplight tracks bids, offers, and trades in DeepLife's shares on secondary markets.